Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06251687

Application of Transbronchial Cryobiopsy in the Diagnosis of Progressive Pulmonary Fibrosis

Application of Transbronchial Cryobiopsy in the Diagnosis of Progressive Pulmonary Fibrosis:a Multicenter Prospective Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
China-Japan Friendship Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical study is to learn about the diagnostic effectiveness, safety, and influencing factors of transbronchial cryobiopsy(TBLC)in progressive pulmonary fibrosis. The main question it aims to answer are: • Determine the prognosis, health economics, and therapeutic strategy changes of patients with TBLC retrograde malleable pulmonary fibrosis. Participants will be randomly divided into two groups, and received TBLB or TBLC.

Conditions

Interventions

TypeNameDescription
PROCEDURETransbronchial Cryobiopsy,TBLCTransbronchial lung cryobiopsy (TBLC) is a novel technique that has proved its diagnostic value in various diffuse parenchymal lung diseases
PROCEDURETransbronchial Lung Biopsy,TBLBTransbronchial lung biopsy (TBLB) is a relatively safe technique routinely employed by pulmonologists for the diagnosis of diffuse parenchymal lung disease

Timeline

Start date
2024-02-01
Primary completion
2026-06-30
Completion
2026-12-31
First posted
2024-02-09
Last updated
2025-02-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06251687. Inclusion in this directory is not an endorsement.